Breakthroughs that change patients' lives

At Pfizer, our work is not complete until our medicines and vaccines reach patients’ hands. So we are leading the conversation to create healthcare policies that promote R&D innovation and more importantly, improve patient access and affordability. As an example, we are a strong advocate of value-based partnerships – rewarding providers for quality not quantity – and are actively engaging with key stakeholders in Japan, China, and Europe to champion these outcomes-based healthcare models.